Phase II study of ixabepilone in patients with metastatic breast cancer and a prospective evaluation of its effects on the ultrastructure of neurons
Phase of Trial: Phase II
Latest Information Update: 18 Jul 2017
At a glance
- Drugs Ixabepilone (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 13 Jun 2017 Status changed from recruiting to completed.
- 27 Oct 2010 Planned end date changed from 1 Nov 2010 to 1 Dec 2010 as reported by ClinicalTrials.gov.